TOSYMRA
Peaksumatriptan
NDANASALSPRAY
Approved
Jan 2019
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
20
Mechanism of Action
Serotonin 1b Receptor Agonists
Pharmacologic Class:
Serotonin-1b and Serotonin-1d Receptor Agonist
Clinical Trials (5)
A STUDY TO EVALUATE THE EFFECT OF PF-06651600 ON PHARMACOKINETICS OF SINGLE DOSE SUMATRIPTAN IN HEALTHY PARTICIPANTS.
Started Jun 2020
10 enrolled
Healthy Volunteers
A Study of Lasmiditan When Given With Sumatriptan in Healthy Participants
Started Oct 2017
40 enrolled
Healthy
Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan in Healthy Participants
Started Mar 2017
42 enrolled
Migraine
Study to Evaluate the Effect of Erenumab on Blood Pressure When Given Concomitantly With Subcutaneous Sumatriptan
Started Feb 2016
34 enrolled
Healthy Subjects
A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data
Started Nov 2010
1 enrolled
Migraine Disorders
Loss of Exclusivity
LOE Date
Jul 19, 2031
65 months away
Patent Expiry
Jul 19, 2031